𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pneumomediastinum in interstitial lung disease associated with dermatomyositis and polymyositis

✍ Scribed by Le Goff, Benoit ;Chérin, Patrick ;Cantagrel, Alain ;Gayraud, Martine ;Hachulla, Eric ;Laborde, Fyriel ;Papo, Thomas ;Sibilia, Jean ;Zabraniecki, Laurent ;Ravaud, Philippe ;Puéchal, Xavier


Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
111 KB
Volume
61
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Objective

Spontaneous pneumomediastinum is a rare complication of dermatomyositis (DM) and polymyositis (PM). The aim of this study was to characterize this complication and determine its prognostic factors.

Methods

We retrospectively collected a multicenter series of PM/DM cases complicated by pneumomediastinum. We analyzed all published cases and combined those that were exploitable with ours for an investigation of the factors associated with poor survival.

Results

We collected 11 PM/DM cases complicated by interstitial lung disease and pneumomediastinum. Five of the 9 DM patients had clinically amyopathic DM without muscle weakness and high serum creatine kinase levels. The outcome was favorable in 7 of these patients and 6 had no sequelae. In total, ∼25% of our patients of the 21 analyzable cases studied died within 1 month. With a median followup of 240 days, the cumulative estimated Kaplan‐Meier survival rate was 64% at 1 year and 55% at 2 years. Poor survival was associated with absence of muscle weakness (P = 0.02), initial low vital capacity (P = 0.006), and initial low carbon monoxide diffusion capacity (P = 0.04).

Conclusion

In this first large series of patients with connective tissue disease complicated by pneumomediastinum to be reported, most patients had DM and half amyopathic DM, as in previous reports. Pneumomediastinum may occur before DM diagnosis and may thus reveal DM with minimal or no muscle involvement. Death was associated with an absence of muscle weakness and severe pulmonary involvement before the onset of pneumomediastinum. Corticosteroids and immunosuppressive therapy can result in complete recovery, as in half our cases.


📜 SIMILAR VOLUMES


Treatment of antisynthetase-associated i
✍ Margaret R. Wilkes; Susan M. Sereika; Noreen Fertig; Mary R. Lucas; Chester V. O 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

## Abstract ## Objective To assess the efficacy of tacrolimus in patients with anti–aminoacyl–transfer RNA synthetase (anti‐aaRS)–associated interstitial lung disease (ILD) and idiopathic inflammatory myopathy (IIM). ## Methods Ninety‐eight patients with anti‐aaRS autoantibodies were identified